Related references
Note: Only part of the references are listed.Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers et al.
JOURNAL OF NEUROSURGERY (2015)
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Ziming Du et al.
ONCOTARGET (2015)
High Incidence of Activating TERT Promoter Mutations in Meningiomas Undergoing Malignant Progression
Stephane Goutagny et al.
BRAIN PATHOLOGY (2014)
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas
Miriam J. Smith et al.
JOURNAL OF PATHOLOGY (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
Thomas Kaley et al.
NEURO-ONCOLOGY (2014)
Management of Atypical Cranial Meningiomas, Part 1: Predictors of Recurrence and the Role of Adjuvant Radiation After Gross Total Resection
Sam Q. Sun et al.
NEUROSURGERY (2014)
Management of Atypical Cranial Meningiomas, Part 2: Predictors of Progression and the Role of Adjuvant Radiation After Subtotal Resection
Sam Q. Sun et al.
NEUROSURGERY (2014)
Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis
J. Darr et al.
ONCOGENE (2014)
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5
Malak S. Abedalthagafi et al.
ONCOTARGET (2014)
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2013)
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Miriam J. Smith et al.
NATURE GENETICS (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
Loss of SUFU Function in Familial Multiple Meningioma
Mervi Aavikko et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2-Deficient Target Cell Types
Marianne F. James et al.
MOLECULAR CANCER RESEARCH (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
The clinical implications of medulloblastoma subgroups
Paul A. Northcott et al.
NATURE REVIEWS NEUROLOGY (2012)
Impaired survival and long-term neurological problems in benign meningioma
Hanna van Alkemade et al.
NEURO-ONCOLOGY (2012)
Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri
Pepijn van den Munckhof et al.
NEUROGENETICS (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Alternative Splicing of CHEK2 and Codeletion with NF2 Promote Chromosomal Instability in Meningioma
Hong Wei Yang et al.
NEOPLASIA (2012)
INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics
Travis J. Hollmann et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
OUTCOMES OF WHO GRADE I MENINGIOMAS RECEIVING DEFINITIVE OR POSTOPERATIVE RADIOTHERAPY
Emily Tanzler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas
I. Christiaans et al.
JOURNAL OF MEDICAL GENETICS (2011)
Harnessing Our Opportunity to Make Primary Care Sustainable
Jim McDermott
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes
M. Kalamarides et al.
ONCOGENE (2011)
Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology
Angeliki Louvi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
Xun Zhang et al.
CANCER RESEARCH (2010)
Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status
Stephane Goutagny et al.
CLINICAL CANCER RESEARCH (2010)
SMARCB1 mutations are not a common cause of multiple meningiomas
K. D. Hadfield et al.
JOURNAL OF MEDICAL GENETICS (2010)
Medical therapies for meningiomas
Patrick Y. Wen et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway Laboratory investigation
Mahlon D. Johnson et al.
JOURNAL OF NEUROSURGERY (2010)
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation
Costanza Bacci et al.
NEUROGENETICS (2010)
WHO grade II and III meningiomas: a study of prognostic factors
Anne Durand et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
Marianne F. James et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
MULTIPLE DURAL LESIONS MIMICKING MENINGIOMAS IN PATIENTS WITH CCM3/PDCD10 MUTATIONS
P. Labauge et al.
NEUROLOGY (2009)
Apoptotic Functions of PDCD10/CCM3, the Gene Mutated in Cerebral Cavernous Malformation 3
Leiling Chen et al.
STROKE (2009)
A typical and anaplastic meningiomas: prognostic implications of clinicopathological features
S-Y Yang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
AKT1E17K in human solid tumours
F. E. Bleeker et al.
ONCOGENE (2008)
Nf2/Merlin: a coordinator of receptor signalling and intercellular contact
M. Curto et al.
BRITISH JOURNAL OF CANCER (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Incidental findings on brain MRI in the general population
Meike W. Vernooij et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular signatures define two main classes of meningiomas
Lucia Helena Carvalho et al.
MOLECULAR CANCER (2007)
Molecular genetics of meningiomas:: From basic research to potential clinical applications
Matthias Simon et al.
NEUROSURGERY (2007)
Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac
Helen Morrison et al.
CANCER RESEARCH (2007)
Histological classification and molecular genetics of meningiomas
Markus J. Riemenschneider et al.
LANCET NEUROLOGY (2006)
UV radiation induces delayed hyperrecombination associated with hypermutation in human cells
Stephen T. Durant et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis
F Hamaratoglu et al.
NATURE CELL BIOLOGY (2006)
GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis
S Piaskowski et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma
EA Lusis et al.
CANCER RESEARCH (2005)
Meningioma transcript profiles reveal deregulated notch signaling pathway
IC Cuevas et al.
CANCER RESEARCH (2005)
Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas
C Mawrin et al.
CLINICAL CANCER RESEARCH (2005)
Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas
YH Liu et al.
HUMAN PATHOLOGY (2005)
Prognostic value of allelic losses and telomerase activity in meningiomas
P Leuraud et al.
JOURNAL OF NEUROSURGERY (2004)
Methylation status of TP73 in meningiomas
J Lomas et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L
R Rong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings
O Al-Mefty et al.
JOURNAL OF NEUROSURGERY (2004)
Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways
MD Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
DNA methylation of multiple promoter-associated CpG islands in meningiomas:: relationship with the allelic status at 1p and 22q
MJ Bello et al.
ACTA NEUROPATHOLOGICA (2004)
Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics
O Al-Mefty et al.
JOURNAL OF NEUROSURGERY (2004)
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
M Kalamarides et al.
GENES & DEVELOPMENT (2002)
Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas
J Boström et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Analysis of p73 gene in meningiomas with deletion at 1p
J Lomas et al.
CANCER GENETICS AND CYTOGENETICS (2001)
NF2 status of meningiomas is associated with tumour localization and histology
J Kros et al.
JOURNAL OF PATHOLOGY (2001)
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: Diagnostic and prognostic implications
DX Cai et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18
R Büschges et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells
MD Johnson et al.
JOURNAL OF NEUROSURGERY (2001)
INI1 mutations in meningiomas at a potential hotspot in exon 9
U Schmitz et al.
BRITISH JOURNAL OF CANCER (2001)
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression
M Simon et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
